Richard Jove, Ph.D.
Director, Beckman Research Institute
Deputy Director, Comprehensive Cancer Center
Professor, Division of Molecular Medicine
City of Hope

Richard Jove, Ph.D., a pioneer in identifying STAT proteins as new molecular targets for cancer therapy, joined City of Hope in August 2005 and was named director of Beckman Research Institute in January 2008. Jove is also the deputy director of City of Hope's National Cancer Institute-designated Comprehensive Cancer Center. He is co-leader of the Developmental Cancer Therapeutics Program and also professor in the Division of Molecular Medicine. Prior to joining City of Hope, Jove served as director of the Molecular Oncology Program and associate director of basic research at the H. Lee Moffitt Cancer Center & Research Institute in Florida. Earlier in his career, he was a tenured faculty member at the University of Michigan Medical School in Ann Arbor, where he also served as director of molecular oncology. Jove has published more than 160 original research articles in peer-reviewed journals and has received numerous honors during his career, including the Damon Runyon-Walter Winchell Cancer Fund Postdoctoral Fellowship at Rockefeller University, the American Cancer Society Junior Faculty Research Award at the University of Michigan, and the Morsani Endowed Chair in Molecular Oncology at Moffitt Cancer Center. Jove earned his doctorate in molecular biology from Columbia University and received postdoctoral training in cancer research at Rockefeller University.